For the eighth consecutive year, the Fundació Parc Científic Universitat de València (FPCUV) has been in charge of organizing the VLC/Startup call, the support program for innovative companies, which is part of a collaboration agreement signed between the Universitat de València and Banco Santander, with the aim of promoting and supporting the creation and consolidation of companies in the university environment of innovation.
"These awards recognize, above all, innovative applications of knowledge and technological development. In the winning companies, the diversity of disciplines and areas of application should be highlighted," explains Pedro Carrasco, director of the PCUV and member of the Committee. On these criteria, the most highly valued project in the Laboratory category corresponds to Evolving Therapeutics (One Phage Solutions Project), a company focused on the fight against multidrug-resistant bacteria, which seeks to develop products capable of preventing, treating and diagnosing bacterial diseases that are currently untreatable. As for the Seedbed modality, the most highly rated companies are Sociocoop Al Detall Coop, Robinfy, Universal Seanergy, Datipic, S.L., Datanow and Deepsense.
Pedro Carrasco, director of the PCUV during the awards ceremony of the eighth edition of VLC/Startup. Photo: PCUV
"These awards recognize, above all, innovative applications of knowledge and technological development. Among the winning companies, the diversity of disciplines and areas of application is noteworthy," explains Pedro Carrasco, director of the PCUV and member of the Committee.
Along with Carrasco, Rosa Donat, vice rector of Innovation and Transfer of the UV and José Miguel Lorente, director of Institutions in the Territorial Management of the Valencian Community and Murcia of Banco Santander also participated in the awards ceremony. For her part, Donat stressed that "this type of initiative is one of the basic pillars on which we want to build the transparency policy of the University of Valencia."
Donat added that "the support and accompaniment part of the VLC/Startup program is essential, since what matters is that companies are integrated into the productive fabric of the community and produce wealth and quality jobs that within the Science Park will necessarily be related to the ability of the UV to feed this quality employment." Along the same lines, Lorente highlighted the "upward collaboration" that has been going on for 25 years between the University of Valencia and Banco Santander.
From right to left: Rosa Donat, vice rector of Innovation and Transfer of the UV; Pedro Carrasco, director of the PCUV; and José Miguel Lorente, director of Institutions in the Territorial Directorate Valencian Community and Murcia of Banco Santander. Photo: PCUV
"This type of initiative is one of the basic pillars on which we want to build the transparency policy of the University of Valencia," Rosa Donat, Vice Rector for Innovation and Transfer of the UV.
Opportunities and challenges of scientific entrepreneurship
During the VLC/Startup awards ceremony, a round table discussion was held, inviting representatives of companies that have received awards in past editions of these prizes. Under the title "From research to entrepreneurship: opportunities and challenges of scientific entrepreneurship", it was attended by Eva García, COO of EpiDisease; Carlos Martí-Gastaldo, co-founder of Porous Materials in Action (PMA); Carmen Ivorra, scientific director of Sequencing Multiplex, and Ángel Tolosa, CEO of Digital Optical Imaging Technologies (DOIT).
One of the points that marked the round table was the importance of scientific entrepreneurship, which was reflected in the direct experiences of the participants, and in his case, Martí-Gastaldo, stressed that "the base that makes up Porous are researchers, so entrepreneurship from our perspective is basically an obligation," since "what you really want is to demonstrate at a social level that what we do has an impact, and the vehicle to do that, unfortunately, is not so much research, but transfer."
In the case of Eva García and Carmen Ivorra, with a long history in their companies, they highlighted the difficulties that exist for entrepreneurial projects to succeed. "In other words, you have to do the same things with the resources of a small company as a multinational," lamented García. For her part, the scientific director of Sequencing Multiplex pointed out that "more than starting up again, it is about redirecting. I think that even if you have a plan and a very well organized strategy, you have to have the guts to change. You have to change the mentality of scientist for flexible scientist," to go beyond the laboratory bench.
Finally, Ángel Tolosa stressed that for DOIT "one of the objectives is not to fall into the typical startup paradigm," since "the vast majority of us are physicists and we apply our knowledge, as we have always done, to the development of the image." In line with the other speakers, he stressed that "now we not only have the opportunity to do it in the scientific field but we want to take it further, that is our challenge."
Round table "From research to entrepreneurship: opportunities and challenges of scientific entrepreneurship", with the participation of Eva García, COO of EpiDisease; Carlos Martí-Gastaldo, co-founder of Porous Materials in Action (PMA); Carmen Ivorra, scientific director of Sequencing Multiplex, and Ángel Tolosa, CEO of Digital Optical Imaging Technologies (DOIT). Moderated by Kristin Suleng, PCUV communications and marketing manager. Photo: PCUV
These are the awarded companies
Among the advantages for the beneficiary companies offered by this program are the possibility of being physically installed in the PCUV, access to both scientific and business support services offered by the FPCUV and the UV, participate in a specific training program aimed at entrepreneurs, and receive an economic endowment. The awards also have two modalities: six awards correspond to the Seedbed modality, with a cash prize of 1,500 euros, plus the installation in one of the coworking spaces of the PCUV for twelve months for free; and a prize for Laboratory modality, which includes a cash prize of 3,000 euros and the assignment of a laboratory space free of charge for a year.
With the support of